Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Creators
Ziabul Hossain
No social account linked
Launched
4mo ago
2026-08-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI-powered operating system for modern healthcare facilities

    Aug 6 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2026-05-20

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Doctor's Page
৳2/ patient
Diagnostic Center
৳3/ patient
Hospital
৳4/ admission
Pharmacy
৳0.50/ sale

Trial: Every new customer gets a 15-day free trial, which starts when you create your first facility or doctor page — additional facilities or pages you add share the same trial window. · Observed 2026-11-06 · Pricing page

Website snapshots

Indexed 2026-08-06

Key pages

Desktop & mobile archive
biomedixai.com/ Snapshot 2026-11-06

Questions & evidence

How much does BioMedixAI cost?
Doctor's Page: ৳2/ patient; Diagnostic Center: ৳3/ patient; Hospital: ৳4/ admission; Pharmacy: ৳0.50/ sale. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does BioMedixAI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is BioMedixAI and what platforms does it support?
BioMedixAI is catalogued under Healthcare & Care Providers: Find a doctor.Book in seconds. Supported platforms: Web.

Related products in this category

Industry Software / Healthcare & Care Providers

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.